te Boekhorst Paul Francis Olivier's Form 4/A amendment
AmendedImmucell Corp (ICCC) · filed Dec 4, 2025
- Accession no.
- 0001437749-25-036913
- Filed
- Dec 4, 2025
- Trade date
- Dec 3-4, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
- Original filed
- Dec 3, 2025
This filing lists 2 non-derivative transactions. It carries over 2 transactions from the original filing that it did not restate. Open-market purchases total $67.3K. It was filed 1 day after the trade.
This amendment restates part of 0001437749-25-036794 (filed Dec 3, 2025). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| te Boekhorst Paul Francis OlivierCIK 0002095704 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2025 | Common Stock $0.10 par value per share | PPurchaseAcquired | +3,598 | $5.05 | +$18,169.9 | 7,306 | Direct | |
| Dec 4, 2025 | Common Stock $0.10 par value per share | PPurchaseAcquired | +2,432 | $5.50 | +$13,376 | 9,738 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001437749-25-036794 (filed Dec 3, 2025).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock $0.10 par value per share | PPurchaseAcquired | +3,708 | $4.87 | +$18,057.96 | 3,708 | Direct | |
| Dec 3, 2025 | Common Stock $0.10 par value per share | PPurchaseAcquired | +3,521 | $5.04 | +$17,745.84 | 9,785 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased.
- F2
This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date.